BDBM548522 WO2022093881, Ex-10.31::WO2022093881, Ex-10.69

SMILES C[C@]1(COC[C@@H]1O)N1CCN(CC1)c1cc2cc(NC(=O)[C@@H]3C[C@@H]3C3CCOCC3)ncc2cc1Cl

InChI Key InChIKey=WDTCEMQXDLLGNQ-VAMBPCRVSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 548522   

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM548522(WO2022093881, Ex-10.31 | WO2022093881, Ex-10.69)
Affinity DataIC50:  0.0800nMAssay Description: The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen™ technology from Life Technologies Corporation (Carlsbad, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM548522(WO2022093881, Ex-10.31 | WO2022093881, Ex-10.69)
Affinity DataIC50:  0.0800nMAssay Description: The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen™ technology from Life Technologies Corporation (Carlsbad, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed